immunomodulator
Showing 1 - 25 of 290
Multiple Myeloma Trial in Shanghai (Selinexor, Thalidomide, Lenalidomide)
Recruiting
- Multiple Myeloma
- Selinexor
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Mar 3, 2022
Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)
Not yet recruiting
- Hepatocellular Carcinoma
- TACE(transcatheter arterial chemoembolization)
- +2 more
- (no location specified)
Jun 5, 2023
Immune Deficiency Trial in Burnaby (QBKPN SSI, Normal Saline Placebo)
Not yet recruiting
- Immune Deficiency
- QBKPN SSI
- Normal Saline Placebo
-
Burnaby, British Columbia, CanadaQu Biologics Trial Site
Jun 13, 2022
Multiple Myeloma Trial in Tianjin (Anlotinib Hydrochloride Capsule)
Recruiting
- Multiple Myeloma
- Anlotinib Hydrochloride Capsule
-
Tianjin, Tianjin, ChinaInstituteHBDH
Sep 18, 2022
Cutaneous Neurofibroma Trial in New York (DPCP)
Not yet recruiting
- Cutaneous Neurofibroma
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jun 24, 2022
Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)
Recruiting
- Glioblastoma Multiforme of Brain
- Multipeptide plus XS15
-
Tübingen, BW, GermanyUniversity Hospital Tübingen
May 9, 2022
Colorectal Cancer, Liver Metastases Trial (QBECO, Placebo)
Not yet recruiting
- Colorectal Cancer
- Liver Metastases
- QBECO
- Placebo
- (no location specified)
Jan 6, 2023
Cutaneous Metastases Trial in New York (Diphencyprone (DPCP))
Not yet recruiting
- Cutaneous Metastases
- Diphencyprone (DPCP)
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 28, 2022
SARS-CoV Infection Trial in Chicago (Vitamin D3 or Placebo, Doctella telehealth monitoring)
Withdrawn
- SARS-CoV Infection
- Vitamin D3 or Placebo
- Doctella telehealth monitoring
-
Chicago, IllinoisNorthwestern University
Feb 4, 2022
Hydroxychloroquine Trial in Assiut (Hydroxychloroquine, Folic acid, Low-dose aspirin)
Recruiting
- Hydroxychloroquine
- Hydroxychloroquine
- +3 more
-
Assiut, EgyptAbdel-rahman Mahmoud Mohammed
Jul 21, 2021
Relapsed/Refractory Peripheral T-cell Lymphoma Trial in Suzhou (Anti-PD-1 mAb, Lenalidomide, Azacitidine)
Recruiting
- Relapsed/Refractory Peripheral T-cell Lymphoma
- Anti-PD-1 monoclonal antibody
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 21, 2021
Covid19, Respiratory Disease, Immune System Trial in Plovdiv (Viusid, Asbrip, Standard Care)
Completed
- Covid19
- +5 more
- Viusid
- +2 more
-
Plovdiv, Bulgaria
- +1 more
Oct 20, 2021
Cytokine Hemadsorption in Covid 19 Bacterial Sepsis
Recruiting
- INTERLEUKIN 6
- cytokine hemadsorption
-
Istanbul, Küçükçekmece, TurkeyBiruni University
Jun 9, 2021
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester
Recruiting
- Plasma Cell Myeloma
- +3 more
- Bone Marrow Biopsy
- +3 more
-
Phoenix, Arizona
- +2 more
Jan 18, 2023
NLR and Survival Among Advanced Lung Cancer Patients Receiving
Completed
- Advanced Lung Cancer
-
Taichung, TaiwanChung Shan Medical University Hospital
Jun 30, 2020
Coronavirus Disease 2019 (COVID-19) Trial in United States (CD24Fc, Placebo)
Completed
- Coronavirus Disease 2019 (COVID-19)
- CD24Fc
- Placebo
-
Jacksonville, Florida
- +9 more
Oct 13, 2021
Periodontitis Trial in Viña Del Mar (Lactose tab, Omega 3)
Completed
- Periodontitis
- Lactose tab
- Omega 3
-
Viña Del Mar, Valparaíso, ChileUniversidad Nacional Andres Bello
May 19, 2020
Crohn Disease Trial in Philadelphia (Crohn Disease Exclusion Diet, Free Diet)
Completed
- Crohn Disease
- Crohn Disease Exclusion Diet
- Free Diet
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Sep 29, 2020
Inflammatory Bowel Disease, Ulcerative Colitis, Crohn's Disease Trial in Indianapolis (Azathioprine, 6 mercaptopurine,
Terminated
- Inflammatory Bowel Disease
- +2 more
- Azathioprine
- +2 more
-
Indianapolis, IndianaIndiana University Hospital
Oct 15, 2019
HIV-1-infection, CD4+ T Lymphocytopenia, Immune Deficiency Trial in Ciudad de México (Pyridostigmine Bromide, Placebo)
Suspended
- HIV-1-infection
- +3 more
- Pyridostigmine Bromide
- Placebo
-
Ciudad de México, Tlalpan, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Apr 8, 2020
Mental Disorder Trial in France (immunomodulatory treatment by rituximab)
Not yet recruiting
- Mental Disorder
- immunomodulatory treatment by rituximab
-
Bordeaux, France
- +8 more
Jul 7, 2023
Skin Inflammation, Allergic Contact Dermatitis Trial in Worcester (drug, other, device)
Recruiting
- Skin Inflammation
- Allergic Contact Dermatitis
- Squaric Acid Dibutyl Ester
- +12 more
-
Worcester, MassachusettsUniversity of Massachusetts Chan Medical School
Sep 6, 2022
MDS Trial in Beijing (Lenalidomide, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023